Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study

被引:31
|
作者
Jouvet, J. C. [1 ]
Thomas, L. [2 ]
Thomson, V. [1 ]
Yanes, M. [1 ]
Journe, C. [1 ]
Morelec, I. [3 ]
Bracoud, L. [4 ]
Durupt, F. [2 ]
Giammarile, F. [3 ]
Berthezene, Y. [1 ]
机构
[1] Univ Lyon 1, Ctr Hosp Croix Rousse, Dept Radiol, F-69365 Lyon, France
[2] Univ Lyon 1, Ctr Hosp Lyon Sud, Dept Dermatol, F-69365 Lyon, France
[3] Univ Lyon 1, Ctr Hosp Lyon Sud, Dept Nucl Med, F-69365 Lyon, France
[4] BioClinica, Lyon, France
关键词
CELL LUNG-CANCER; COMPUTED-TOMOGRAPHY; BONE METASTASES; IMAGING DWI; DIAGNOSIS; UTILITY; SYSTEM;
D O I
10.1111/jdv.12078
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
ObjectivesThe aim of our study was to compare the diagnostic performances of non-radiating whole-body magnetic resonance imaging (wbMRI), either volumetric, with Volumetric interpolated breath-hold examination (VIBE) or metabolic, with diffusion-weighted sequences (wbMRI), with classical irradiating techniques such as PET-CT, CT and with lymph node ultrasonography (US) for the staging of advanced melanoma. Patients and methodsThirty-seven melanoma AJCC stage IV patients were prospectively included. All images were independently interpreted without prior knowledge of the results of studies performed with concurrent techniques, and all imaging techniques were scheduled within a mean interval of 7days. The overall and site-specific diagnosis performances of each imaging modality were studied, as well as the interest of combined MRI VIBE and diffusion sequences. ResultsThe number of visceral or lymph node metastases spotted was, respectively, 218, with 125 metastases for wbMRI, 191/103 for PET-CT, 209/115 for CT and 33/13 for lymph node US. No statistically significant difference (P<0.05) of overall diagnostic performances between wbMRI (Se 84%, Sp 87.1%, PPV 89.8%, NPV 80.2%) and PET-CT (Se 79.8%, Sp 93.1%, PPV 93.2%, NPV 79.4%) was observed. No statistically significant difference was found between wbMRI and PET-CT with two channels for CT with respect to different metastatic sites. Compared with the CT, wbMRI had significantly better overall specificity (P=0.0011) and PPV (P=0.02). For lung exploration, sensitivity of wbMRI (51.6%) was inferior to CT (71.4%). To detect superficial metastatic lymph nodes, wbMRI and US both showed high diagnostic accuracy with no statistically significant difference. Intra-observer agreement was almost perfect for all imaging modalities considering the overall staging. Inter-observer agreement for wbMRI and diffusion alone was almost perfect except for bone and lymphatic sites. Overall diagnostic performance of diffusion alone was significantly inferior to those of combined VIBE and diffusion sequences. ConclusionsWhole-body MRI, using diffusion weighted sequences, was a reliable non-radiating imaging for staging of melanoma and offers the same diagnostic performances than combined CT, PET-CT and lymph node US.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 50 条
  • [31] Whole-body MRI, including diffusion-weighted imaging, compared to FDGPET/CT for staging newly diagnosed lymphoma: Initial results
    Kwee, Thomas
    De Klerk, John
    Fijnheer, Rob
    van Ufford, Henriette Quarles
    Beek, Frederik
    Takahara, Taro
    Mali, Willem
    Nievelstein, Rutger
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [32] 68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study
    Petersen, Lars J.
    Nielsen, Julie B.
    Langkilde, Niels C.
    Petersen, Astrid
    Afshar-Oromieh, Ali
    De Souza, Nandita M.
    De Paepe, Katja
    Fisker, Rune, V
    Arp, Dennis T.
    Carl, Jesper
    Haberkorn, Uwe
    Zacho, Helle D.
    WORLD JOURNAL OF UROLOGY, 2020, 38 (04) : 939 - 948
  • [33] 68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study
    Lars J. Petersen
    Julie B. Nielsen
    Niels C. Langkilde
    Astrid Petersen
    Ali Afshar-Oromieh
    Nandita M. De Souza
    Katja De Paepe
    Rune V. Fisker
    Dennis T. Arp
    Jesper Carl
    Uwe Haberkorn
    Helle D. Zacho
    World Journal of Urology, 2020, 38 : 939 - 948
  • [34] Can we replace F-18 FDG PET/CT with whole-body diffusion-weighted MRI as a high quality cancer screening tool?
    Uno, K.
    Sasamori, H.
    Wu, J.
    Akiba, Y.
    Tsuchiya, Y.
    Irie, M.
    Ikeda, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S448 - S448
  • [35] Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI
    Ohno, Yoshiharu
    Yoshikawa, Takeshi
    Takenaka, Daisuke
    Koyama, Hisanobu
    Aoyagi, Kota
    Yui, Masao
    Oshima, Yuka
    Hamabuchi, Nayu
    Tanaka, Yumi
    Shigemura, Chika
    Oota, Seiichiro
    Nomura, Masahiko
    Murayama, Kazuhiro
    Inui, Yoshitaka
    Kikukawa, Kaoru
    Toyama, Hiroshi
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (05) : 899 - 908
  • [36] Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study)
    Fischerova, D.
    Pinto, P.
    Burgetova, A.
    Masek, M.
    Slama, J.
    Kocian, R.
    Fruhauf, F.
    Zikan, M.
    Dusek, L.
    Dundr, P.
    Cibula, D.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2022, 59 (02) : 248 - 262
  • [37] Comparison of Whole-Body Versus Limited Whole-Body 18F-FDG PET/CT Scan in Malignant Cutaneous Melanoma
    Lazaga, Francisco Jose
    Oez, Orhan K.
    Adams-Huet, Beverley
    Anderson, Jon
    Mathews, Dana
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (11) : 882 - 884
  • [38] Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT
    Kirchner, Julian
    Sawicki, Lino Morris
    Suntharalingam, Saravanabavaan
    Grueneisen, Johannes
    Ruhlmann, Verena
    Aktas, Bahriye
    Deuschl, Cornelius
    Herrmann, Ken
    Antoch, Gerald
    Forsting, Michael
    Umutlu, Lale
    PLOS ONE, 2017, 12 (02):
  • [39] FDG PET-CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy
    Jeong, In Gab
    Hong, Sungwoo
    You, Dalsan
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (09) : 3150 - 3156
  • [40] Usefulness of both PET/CT with F18-FDG and whole-body diffusion-weighted imaging in cancer screening: a preliminary report
    Hiroto Sasamori
    Kimiichi Uno
    Jin Wu
    Annals of Nuclear Medicine, 2019, 33 : 78 - 85